Transcranial Direct Current Stimulation in Offenders

October 17, 2022 updated by: Olivia Choy

The Effect of Transcranial Direct Current Stimulation on Risk-taking and Aggression in Offenders

This study investigates the effect of upregulating prefrontal cortex activity on risk-taking, and antisocial and aggressive behavior in violent offenders. In the double-blind, randomized controlled trial, using a within-subject crossover design, each participant will undergo anodal transcranial direct current stimulation of the right dorsolateral prefrontal cortex and sham stimulation. After each stimulation session, neural activity and behavioral responses to tasks assessing risk-taking and aggressive behavior will be recorded. The effect of tDCS on violent offenders will also be assessed in comparison to age and gender-matched healthy controls.

Study Overview

Study Type

Interventional

Enrollment (Actual)

41

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Aachen, Germany, 52074
        • Uniklinik RWTH Aachen

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Between 18 and 50 years of age
  • Able to understand the nature of the study and give informed consent
  • Individuals in the violent offender group must have a record of repeated violent criminal offending (at least 2 felonies).
  • Individuals in the violent offender group must have been convicted solely due to crimes involving violence motivated by impulsive aggression.

Exclusion Criteria:

  • Presence of any contraindications for functional magnetic resonance imaging (fMRI)
  • History of significant medical illness
  • History of any neurological condition
  • Diagnosis of schizophrenia
  • History of epilepsy
  • Head injury
  • Mental retardation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: BASIC_SCIENCE
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Anodal stimulation
Participants in the active stimulation group will undergo anodal transcranial direct current stimulation (tDCS). tDCS will be delivered by a battery-driven, constant-current stimulator connected to two saline-soaked surface sponge electrodes. An anodal electrode (25cm2) will be placed over the right dorsolateral prefrontal cortex and one cathodal electrode (100cm2) will be placed over the left supraorbital area at least 5cm from the anode. Scalp electrodes will be positioned according to the 10-20 EEG international system. A current of 2mA will be applied for 20 minutes and the current will be ramped up and down over 20 seconds at the beginning and end of the stimulation period.
Transcranial direct current stimulation will be administered for 20 minutes using a CE approved stimulator (NeuroConn, Ilmenau, Germany).
SHAM_COMPARATOR: Sham stimulation
The sham tDCS condition will involve the same placement of the electrodes, current intensity, and ramp-up/down time as the active tDCS condition, but stimulation will only last for 30 seconds.
The same device will be used as in the active stimulation group, but stimulation will be terminated after 30 seconds.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of balloon pumps in the Balloon Analogue Risk Task after stimulation
Time Frame: Within 1 hour after the 20-minute tDCS or sham session ends
The number of balloon pumps, measured by the number of times subjects press a button to pump up a computerized balloon over 60 trials, will be assessed.
Within 1 hour after the 20-minute tDCS or sham session ends
Neural activity during Balloon Analogue Risk Task after stimulation
Time Frame: Within 1 hour after the 20-minute tDCS or sham session ends
Functional brain activity and connectivity will be assessed using functional magnetic resonance imaging.
Within 1 hour after the 20-minute tDCS or sham session ends
Aggressive behavior after stimulation
Time Frame: Within 1 hour after the 20-minute tDCS or sham session ends
This will be assessed according to performance on the violent video game, Carmageddon: TDR 2000 (Klasen et al., 2013; Torus Games, Bayswater, Australia, 2000) in comparison to a modified non-violent version of the game.
Within 1 hour after the 20-minute tDCS or sham session ends
Neural activity during aggression task after stimulation
Time Frame: Within 1 hour after the 20-minute tDCS or sham session ends
Functional brain activity and connectivity during participation in the video game will be assessed using functional magnetic resonance imaging.
Within 1 hour after the 20-minute tDCS or sham session ends
Antisocial behavior inclinations after stimulation
Time Frame: Within 1 hour after the 20-minute tDCS or sham session ends
This will be assessed using 8 hypothetical scenarios in which someone commits a criminal or antisocial act. Participants will respond to the likelihood that they would commit the act in the scenario according to a 10-point Likert scale.
Within 1 hour after the 20-minute tDCS or sham session ends

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of participants with adverse events
Time Frame: Within 1 hour after the 20-minute tDCS or sham session ends
The number of participants reporting the experience of sensations resulting from tDCS will be recorded.
Within 1 hour after the 20-minute tDCS or sham session ends
Ratings of guilt or shame regarding antisocial acts after stimulation
Time Frame: Within 1 hour after the 20-minute tDCS or sham session ends
This will be assessed using 8 hypothetical scenarios in which someone commits a criminal or antisocial act. Participants will respond to the likelihood that they would feel a sense of guilt or shame according to a 10-point Likert scale.
Within 1 hour after the 20-minute tDCS or sham session ends
Ratings of moral wrongfulness regarding antisocial acts after stimulation
Time Frame: Within 1 hour after the 20-minute tDCS or sham session ends
This will be assessed using 8 hypothetical scenarios in which someone commits a criminal or antisocial act. Participants will rate the moral wrongfulness of the acts according to a 10-point Likert scale.
Within 1 hour after the 20-minute tDCS or sham session ends

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Ute Habel, PhD, RWTH Aachen University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 1, 2017

Primary Completion (ACTUAL)

June 1, 2021

Study Completion (ACTUAL)

June 1, 2022

Study Registration Dates

First Submitted

January 26, 2017

First Submitted That Met QC Criteria

January 26, 2017

First Posted (ESTIMATE)

January 30, 2017

Study Record Updates

Last Update Posted (ACTUAL)

October 18, 2022

Last Update Submitted That Met QC Criteria

October 17, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • EK 341/16

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aggression

Clinical Trials on Transcranial direct current stimulation

3
Subscribe